Alpha- and Beta-thalassemia: Rapid Evidence Review.

Area of Science:

• Hematology
• Genetics
• Pediatrics

Background:

• Thalassemia encompasses inherited blood disorders affecting hemoglobin production.
• It leads to ineffective erythropoiesis, red blood cell destruction, and anemia.
• Severe forms manifest in early childhood, requiring lifelong management.

Purpose of the Study:

• To provide a comprehensive overview of thalassemia.
• To highlight diagnostic approaches and management strategies.
• To discuss complications and long-term prognosis.

Main Methods:

• Review of existing literature on thalassemia.
• Analysis of diagnostic criteria including hemoglobin electrophoresis and genetic testing.
• Summary of current and emerging treatment modalities.

Main Results:

• Thalassemia diagnosis relies on clinical suspicion (microcytic anemia, elevated ferritin) and confirmed by genetic testing.
• Disease severity varies, from asymptomatic carriers to life-threatening conditions like alpha-thalassemia major.
• Effective management involves transfusions, iron chelation, and other therapies, improving life expectancy.

Conclusions:

• Thalassemia requires lifelong management, with significant improvements in life expectancy due to advances in care.
• Genetic counseling and screening are crucial for high-risk populations.
• Ongoing research aims to further improve treatment and reduce disease burden.